Endocrine Testing Market, By Test (Thyroid, Insulin, Follicle Stimulating Hormone, Luteinizing, Hormone, Estradiol, Testosterone, Progesterone, Human chorionic gonadotropin, Prolactin, Cortisol DHEA-S, and Others), By Diagnostic Technology (Immunoassay, Tandem Mass Spectroscopy, Monoclonal and Polyclonal Antibody, Sensor Technologies, Clinical Chemistry, and Others), By End User (Hospitals, Diagnostic Laboratories and others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis, and Forecast till 2030

Report Code: PMI9518 | Publish Date: March 2024 | No. of Pages: 168

Global Endocrine Testing Market By Overview

Endocrine testing market accounted for US$ 181.47 billion in 2020 and is estimated to be US$ 869.6 billion by 2030 and is anticipated to register a CAGR of 8.9%.

The endocrine system comprises hormones and group of glands that carry hormones directly to the circulatory system. Thyroid gland and the adrenal glands are major glands in humans, which operate various body activities such as growth and development, metabolism, reproduction, stimuli response, and homeostasis. Imbalance in hormone concentration leads to certain disorder, which can be used as marker to diagnose certain condition. Endocrine testing involves testing of the hormones such as thyroid stimulating hormone, insulin, human chorionic gonadotropin, follicle stimulating hormones, progesterone, cortisol, prolactin, testosterone, and other hormones.

Global Endocrine Testing Market By Dynamics

High prevalence of endocrine disorders

Endocrine testing measures endocrine hormone concentration to diagnose the various disorders such as diabetes, hypothyroidism, infertility, and other hormonal disorder. Moreover, high prevalence of endocrine disorders such as diabetes, hypo/hyperthyroidism, infertility, multiple endocrine neoplasia 1 and 2, hypo/hyperadrenocorticism and hypogonadism are expected to drive growth of endocrine testing market over the forecast period. However, high cost of advanced endocrine testing technologies in emerging economies is restraining growth of the market. Furthermore, lack of awareness regarding diagnostics tests among populations is hindering market growth.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Endocrine Testing Market By Segmentation

Endocrine testing market is segmented on the basis of test, diagnostic technology, end user, and region. On the basis of type, endocrine testing market is segmented into thyroid, insulin, follicle stimulating hormone, luteinizing, hormone, estradiol, testosterone, progesterone, human chorionic gonadotropin, prolactin, cortisol DHEA-S, and others. On the basis of by diagnostic technology, endocrine testing market is segmented into immunoassay, tandem mass spectroscopy, monoclonal and polyclonal antibody, sensor technologies, clinical chemistry, and others. On the basis of end user endocrine testing market is segmented into hospitals, diagnostic laboratories and others. On the basis of region, endocrine testing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Regional Insights:

On region the endocrine testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to have a considerable share due to factors such as well-established healthcare infrastructure, high prevalence of obesity, developments in diagnostic technologies, and new product launches. The market is expected to rise due to a decrease in physical activity and an increase in the incidence of thyroid problems.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2030

Market Segmentation

By Test - Thyroid, Insulin, Follicle Stimulating Hormone, Luteinizing, Hormone, Estradiol, Testosterone, Progesterone, Human Chorionic Gonadotropin, Prolactin, Cortisol DHEA-S, And Others

By Diagnostic Technology – Immunoassay, Tandem Mass Spectroscopy, Monoclonal And Polyclonal Antibody, Sensor Technologies, Clinical Chemistry, And Others

By End User – Hospitals, Diagnostic Laboratories And Others

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at , regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2030. For the purpose of this study, has segmented the endocrine testing market report based on Test, Diagnostic Technology, End User and Region.

Endocrine Testing Market, By Region:

      • North America
        • U.S.
        • Canada
      • Europe
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
      • Asia Pacific
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
      • Latin America
        • Brazil
        • Mexico
        • Rest of Latin America
      • Middle East & Africa
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

Global Endocrine Testing Market By Key Players

Key players operating in endocrine testing market include Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Inc., Siemens Healthineers, bioMérieux SA, Agilent Technologies, BioRad Laboratories, AB Sciex, F-Hoffmann La Roche AG, and Quest Diagnostics.

Global Endocrine Testing Market By Company Profile

  • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Thermo Fisher Scientific
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Beckman Coulter, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Siemens Healthineers
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • bioMérieux SA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Agilent Technologies
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • BioRad Laboratories
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AB Sciex
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • F-Hoffmann La Roche AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Quest Diagnostics
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

Global Endocrine Testing Market By Table of Contents

Research Objective and Assumption

  • Preface
  • Research Objectives
  • Study Scope
  • Years Considered for the study
  • Assumptions
  • Abbreviations

Research Methodology

  • Research data
  • Primary Data
    • Primary Interviews
    • Primary Breakdown
    • Key data from Primary Sources
    • Key Thickness Insights
  • Secondary Data
    • Major Secondary Sources
    • Secondary Sources
  • Market Estimation
  • Top-Down Approach
    • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
  • Bottom-Up Approach
    • Approach for estimating market share by Bottom-up Analysis (Demand Side)
  • Market Breakdown and Data Triangulation
  • Research Assumptions

Market Preview

  • Executive Summary
  • Key Findings—Global Outlook for medical carts Strategies
    • Key Questions this Study will Answer
    • Market Snippet, By Test
    • Market Snippet, By Diagnostic Technology
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Opportunity Map Analysis
  • Executive Summary—3 Big Predictions

Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restrains
    • Market Opportunities
    • Market Trends
  • DR Impact Analysis
  • PEST Analysis
  • Porter’s Five Forces Analysis
  • Opportunity Orbit
  • Market Investment Feasibility Index
  • Macroeconomic Factor Analysis

Market Segmentation, By Test, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Thyroid
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Insulin
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Follicle Stimulating Hormone
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Luteinizing
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Hormone
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Estradiol
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Testosterone
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Progesterone
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Human chorionic gonadotropin
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Prolactin
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Cortisol DHEA-S
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Diagnostic Technology, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Immunoassay
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Tandem Mass Spectroscopy
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Monoclonal and Polyclonal Antibody
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Sensor Technologies
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Clinical Chemistry
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By End User, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Diagnostic Labortories
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Others
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Global Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Regional Trends
  • North America
    • Market Size and Forecast (US$ Bn), By Test, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Diagnostic Technology, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast (US$ Bn), By Test, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Diagnostic Technology, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • UK
      • France
      • Germany
      • Russia
      • Italy
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast (US$ Bn), By Test, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Diagnostic Technology, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • India
      • Japan
      • South Korea
      • China
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast (US$ Bn), By Test, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Diagnostic Technology, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Test, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Diagnostic Technology, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By End User, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East

Competitive Landscape

  • Heat Map Analysis
  • Market Presence and Specificity Analysis

Company Profiles

  • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Bayer AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AbbVie Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • F. Hoffmann-La Roche Ltd.  
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • GlaxoSmithKline plc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Eli Lilly and Company   
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • AstraZeneca   
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cipla Inc.  
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

The Last Word                                 

  • Future Impact
  • About Us
  • Contact

FAQs

Endocrine testing market is segmented on the basis of test, diagnostic technology, end user, and region.

High prevalence of endocrine disorders such as diabetes, hypo/hyperthyroidism, infertility, multiple endocrine neoplasia 1 and 2, hypo/hyperadrenocorticism and hypogonadism are expected to drive growth of endocrine testing market over the forecast period

The North America dominates the cell culture market owing to increasing presence of biopharmaceutical industries with increasing demand of precision medicine.

Key players operating in endocrine testing market include Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Inc., Siemens Healthineers, bioMérieux SA, Agilent Technologies, BioRad Laboratories, AB Sciex, F-Hoffmann La Roche AG, and Quest Diagnostics.

High cost of advanced endocrine testing technologies in emerging economies is restraining growth of the market